全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Tetanus Toxin Antibody Levels in Pre-School Nigerian Children after Three Doses of Diphtheria-Pertussis-Tetanus/Pentavalent Immunization: A Cross-Sectional Study

DOI: 10.4236/wjv.2018.82005, PP. 39-52

Keywords: DPT/Pentavalent Vaccine, Antibodies, Response

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Post-neonatal tetanus is an important problem. Prevention of tetanus in Nigeria is via immunization with three doses of Diphtheria-Pertussis-Tetanus (DPT)/Pentavalent vaccine at 6, 10 and 14 weeks. The anti-tetanus antibody levels of these children are not known after they had received DPT3/Pentavalent vaccines. Aim: This work was to determine the anti-tetanus antibody (IgG) response in Nigerian children aged six months to five years who had received three doses of DPT vaccine in early infancy. Methods: Children aged six months to five years who were attended to in the University of Calabar Teaching Hospital for acute illnesses were recruited. Their anti-tetanus IgG levels were measured using Enzyme Linked Immunosorbent Assay (ELISA). The optimal cut-off level of ≥0.1 IU/ml was used as the protective level. Data was analysed using the Statistical Package for Social Sciences (SPSS) version 20.0 with simple proportions and percentages. Students’ “t” test and ANOVA were used to compare quantitative variables while Chi-square and Fisher’s exact test were used to compare categorical data. Results: Four hundred and eighteen children participated in the study. The mean IgG antibody level was 1.021 ± 0.9 IU/ml. Four hundred children (95.7%) had protective levels of antibodies. The highest proportion of subjects with protective levels was in infants, 6 - 11 months (99%) and lowest in children aged 36 - 47 months (92.2%). Conclusion: The proportion of children with protective levels was above 90% in all age groups studied. The current national immunization schedule is adequate. Further studies in older age groups are needful.

References

[1]  CDC. (2012) Epidemiology and Prevention of Vaccine-Preventable Diseases. In: CDC, Eds., The Pink Book, 12th Ed., Public Health Foundation, Washington DC, 291-300.
http://www.cdc.gov/vaccines/pubs/pinkbook/tetanus.html
[2]  Ramos, J., Reyes, F. and Tesfamariam, A. (2008) Tetanus in a Rural Ethiopian Hospital. Tropical Doctor, 38, 104-105.
https://doi.org/10.1258/td.2006.006085
[3]  World Health Organization. (2008) Vaccine-Preventable Diseases: Monitoring Systems. Global Summary.
[4]  World Health Organization. (2017) Vaccine-Preventable Diseases: Monitoring System 2010 Global Summary. Immunization, Vaccines and Biologicals.
http://whqlibdoc.who-int/hq/2010/WHO IVB 2010 eng.pdf
[5]  World Health Organization. (2014) Vaccine-Preventable Diseases: Monitoring System. Global Summary.
[6]  Pascual, F., McGinley, E., Zanardi, L., Cortese, M. and Murphy, T. (2003) Tetanus Surveillance, United States. MMWR Surveillance Summary, 52, 1-8.
[7]  Kyu, H., Mumford, J. and Naghavi, M. (2017) Mortality from Tetanus between 1990 and 2015: Findings from the Global Burden of Disease Study 2015. BMC Public Health, 17, 179.
https://doi.org/10.1186/s12889-017-4111-4
[8]  Oyedeji, O.A., Fadero, F., Joel-medewase, V., Elemile, P. and Ademola, G. (2012) Trends in Neonatal and Post-Neonatal Tetanus Admissions at a Nigerian Teaching Hospital. Journal of Infectious Diseases, 6, 847-853.
https://doi.org/10.3855/jidc.2105
[9]  Gbadegesin, R., Adeyemo, A. and Osinusi, K. (1996) Childhood Post-Neonatal Tetanus. Nigerian Journal Paediatrics, 23, 11-15.
[10]  Anah, M., Etuk, I., Ikpeme, O., Ntia, H., Ineji, E. and Archibong, R. (2008) Post-Neonatal Tetanus in Calabar, Nigeria: A 10 Year Review. Nigerian Medical Practitioner, 54, 45-47.
[11]  Oyelami, O., Aladekomo, T. and Ononye, F. (1996) A 10 Year Retrospective Evaluation of Cases of Post-Neonatal Tetanus Seen in a Pediatric Unit of a University Teaching Hospital in South Western Nigeria. Central African Journal of Medicine, 42, 73-75.
[12]  Chukwuka, O., Ezeudu, C. and Nnamani, K. (2015) Neonatal and Post-Neonatal Tetanus in Nnamdi Azikiwe University Teaching Hospital, Nnewi, South-East, Nigeria: A 10-Year Review. Tropical Journal of Medical Research, 18, 30-33.
https://doi.org/10.4103/1119-0388.152552
[13]  Emodi, I.J., Bch, M.B., Ikefuna, A.N. and Obichukwu, C. (2011) Incidence and Outcome of Neonatal Tetanus in Enugu over a 10-Year Period. South African Journal of Community Health, 5, 117-119.
[14]  Ide, L. and Uchenwa-Onyenegecha, T. (2016) Post Neonatal Tetanus: 20 Years Experience as Seen at the University of Port Harcourt Teaching Hospital. British Journal of Medicine and Medical Research, 12, 1-5.
https://doi.org/10.9734/BJMMR/2016/19047
[15]  Ojini, F. and Danesi, M. (2005) Mortality of Tetanus at the Lagos University Teaching Hospital, Nigeria. Tropical Doctor, 35, 178-181.
https://doi.org/10.1258/0049475054620806
[16]  Borrow, R., Balmer, P. and Roper, M. (2006) The Immunologic Basis for Immunization Series-Module 3: Geneva, Switzerland, 2007.
[17]  UNICEF/WHO/UNFPA (2000) Maternal and Neonatal Tetanus Elimination by 2005: Strategies for Achieving and Maintaining Elimination. New York.
[18]  Federal Ministry of Health (2006-2010) Comprehensive NPI Multi-Year Plan.
[19]  Immunisation PAC on (2012) Paediatric Association of Nigeria (PAN) Recommended Routine Immunization Schedule for Nigerian Children. Nigerian Journal of Paediatrics, 39, 152-158.
[20]  Stubbe, M., Mortelmans, L., Desruelles, D., Swinnen, R., Vranckx, M. and Brasseur, E. (2007) Improving Tetanus Prophylaxis in the Emergency Department: A Prospective, Double-Blind Cost-Effectiveness Study. Emergency Medicine Journal, 24, 648-653.
https://doi.org/10.1136/emj.2007.048520
[21]  Simonsen, O., Bentzoss, M. and Heron, I. (1986) ELISA for the Routine Determination of Antitoxin Immunity to Tetanus. Journal of Biological Standards, 14, 231-239.
https://doi.org/10.1016/0092-1157(86)90008-9
[22]  Orimadegun, A.E., Orimadegun, B.E. and Akinlolu, A. (2013) Immunity against Tetanus Infection, Risk Factors for Non-Protection, and Validation of a Rapid Immunotest Kit among Hospitalized Children in Nigeria. Frontiers in Neurology, 4, 142-143.
https://doi.org/10.3389/fneur.2013.00142
[23]  World Health Organization (2006) Child Growth Standards: Length/Height for Age, Weight-for-Age, Weight-for-Length, Weight-for-Heigth and Body Mass Index-for-Age, Methods and Development. Geneva.
[24]  DRG Instruments GmbH G. Tetanus Toxin IgG ELISA.
[25]  Gergen, P.J., Ezza-ti-Rice, T.M. and Russell, H. (1988) DTP Immunization Status and Tetanus Antitoxin Titers of Mexican American Children Ages Six Months through Eleven Years. American Journal of Public Health, 78, 1446-1450.
https://doi.org/10.2105/AJPH.78.11.1446
[26]  Fatunde, O. and Familusi, J. (2001) Post-Neonatal Tetanus in Nigeria—A Need for Booster Doses of Tetanus Toxoid. Nigerian Journal of Paediatrics, 28, 35-38.
https://doi.org/10.4314/njp.v28i2.12053
[27]  Adekanle, O., Ayodeji, O. and Olatunde, L. (2009) Tetanus in a Rural Setting of South-Western Nigeria: A Ten-Year Retrospective Study. Libyan Journal of Medicine, 4, 78-80.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3066715&tool=pmcentrez&rendertype=abstract
[28]  European Centre for Disease Prevention and Control (2009) Scientific Panel on Childhood Immunisation Schedule: Diphtheria-Tetanus-Pertussis (DTP) Vaccination. Stockholm, 1-23.
http://www.ecdc.europa.eu

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413